AFT Pharma has better year

May 23, 2022 | Latest News

AFT Pharmaceuticals CEO Dr Hartley Atkinson 22.5.22 (9.12am) Along with a FY22 operating profit in line with guidance, AFT Pharmaceuticals has struck its dividend policy and guides to a maiden payment in FY23. The company’s 31 March 2022 results show strong growth across all regions, new products and growth in product royalties and licensing income. […]

 


 

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

Your Advertisement Here

Contact us now to discuss advertising options

Your Advertisement Here

Contact us now to discuss advertising options